missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ CDK2 Recombinant Rabbit Monoclonal Antibody (24GB4315)

Rabbit Recombinant Monoclonal Antibody
Brand: Invitrogen™ MA557367
This item is not returnable.
View return policy
Description
CDK2 Recombinant Monoclonal Antibody for Western Blot, Flow
CDK2/cyclinO is a member of the cyclin dependent protein kinase family complexed to CyclinO. CyclinO was used as a specific protein isoform name for the UNG gene which is localized exclusively in the nucleus. In addition, CyclinO was reported to shows significant uracil-DNA glycosylase activity. CDK2/cyclinO protein levels increase during G1 phase and the protein is turned over during the course of cell cycle. The levels of cyclin A-cdk2 is maximal at the G1/S transition and both cdk2 and cyclin A are found associated with DNA in the initiation complex during replication. Rb protein acts as substrate for cdk2-cyclin E and/or cdk2-cyclin A in vivo. Cdk2 is activated and specifically localized to the nucleus during late G1-, S-, and G2-phase.
Specifications
| CDK2 | |
| Recombinant Monoclonal | |
| Unconjugated | |
| CDK2 | |
| A630093N05Rik; CDC28; CDC2A; cdc2-related protein kinase; CDK1; CDK2; CDKN2; Cell division protein kinase 2; cyclin dependent kinase 2; cyclin dependent kinase 2-alpha; cyclin-dependent kinase 2; EC 2.7.11.22; EC 2.7.11.23; kinase Cdc2; MPF; p33 protein kinase; p33(CDK2); p33CDK2; p34 protein kinase | |
| Rabbit | |
| Affinity chromatography | |
| RUO | |
| 1017, 12566, 362817 | |
| -20°C | |
| Liquid |
| Flow Cytometry, Western Blot, Immunocytochemistry | |
| 24GB4315 | |
| PBS with 50% glycerol and 0.02% sodium azide; pH 7.4 | |
| P24941, P97377, Q63699 | |
| CDK2 | |
| A synthesized peptide derived from human Cdk2 (aa 281-298). | |
| 100 μL | |
| Primary | |
| Human, Mouse, Rat | |
| Antibody | |
| IgG |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction